ARCHIVES

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | March 27, 1998

Download PDF Visit The Full Archive

Related Articles

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

Heart Failure Rare Among Leukemia Patients On Imatinib

September 28, 2007

Letter: The Lesson From Dana-Farber

July 28, 1995

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

IOM Committee Advises DOD To Fund Grants; Training, Infrastrucure In Breast Cancer; Goals To Raise Number of New Investigators

May 21, 1993

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007